About Pharmaron
Pharmaron is a company based in Beijing (China) founded in 2003 by Larry Lou, Bei Zheng, and Boliang Lou. Pharmaron has raised $320 million across 5 funding rounds from investors including HHS, CITIC Capital and Legend Capital. The company has 476 employees as of December 31, 2021. Pharmaron has completed 6 acquisitions, including Absorption, Aesica and Allergan. Pharmaron operates in a competitive market with competitors including Lonza, Pfizer, Boehringer Ingelheim, LabConnect and Ainos, among others.
- Headquarter Beijing, China
- Employees 476 as on 31 Dec, 2021
- Founders Larry Lou, Bei Zheng, Boliang Lou
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$320 M (USD)
in 5 rounds
-
Latest Funding Round
$280 M (USD), Private Equity Round
Dec 14, 2015
-
Investors
HHS
& 5 more
-
Employee Count
476
as on Dec 31, 2021
-
Investments & Acquisitions
Absorption
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Pharmaron
Unlock access to complete
Funding Insights of Pharmaron
Pharmaron has successfully raised a total of $320M across 5 strategic funding rounds. The most recent funding activity was a Private Equity Round of $280 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Pharmaron
Pharmaron has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, CITIC Capital and Legend Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture Capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
Tech-focused seed, early, and mid-stage VC investments are made globally.
|
Locked | Locked | Locked | |
|
PE firm investing in the US
|
Locked | Locked | Locked |
Investor details for Pharmaron
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Pharmaron
Pharmaron has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include Absorption, Aesica and Allergan.
Investment portfolio details for Pharmaron
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Full service, early phase CRO specializing in complex trials
|
Locked | Locked | 2006 | Locked | |
|
Contract development and manufacturing organisation (CDMO) for APIs and finished dose forms
|
Locked | Locked | 2004 | Locked | |
|
Accelerator Mass Spectrometry is utilized by Xceleron for pharmaceutical analysis.
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for Pharmaron
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Pharmaron
Detailed financials for Pharmaron
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pharmaron Comparisons
Peer comparison for Pharmaron
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Pharmaron
Pharmaron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lonza, Pfizer, Boehringer Ingelheim, LabConnect and Ainos, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
CDMO services for pharma, biotech, and specialty ingredients are provided.
|
|
| Locked | Locked | Locked |
Pharmaceutical products for treating multiple diseases are provided.
|
|
| Locked | Locked | Locked |
Generic drugs and clinical research services are provided globally.
|
|
| Locked | Locked | Locked |
Laboratory testing, clinical trial research, and biopharma services are provided.
|
|
| Locked | Locked | Locked |
Novel point-of-care testing and low-dose interferon therapeutics are developed.
|
Detailed competitors of Pharmaron
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pharmaron
Complete news archive for Pharmaron
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pharmaron
Pharmaron was founded in 2003 and raised its 1st funding round 5 years after it was founded.
Pharmaron is headquartered in Beijing, China.
Boliang Lou is the current CEO of Pharmaron. They have also founded this company.
Pharmaron is a funded company, having raised a total of $320M across 5 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Pharmaron is 476.
Founded in 2003 and headquartered in Beijing, China, Pharmaron operates in the pharmaceutical sector, focusing on research and development services for small molecules, nucleosides, nucleotides, peptides, lipids, and carbohydrates. Disciplines covered include chemistry, biology, DMPK, pharmacology, toxicology, and formulation development. Expertise encompasses organic synthesis, medicinal chemistry, biologics engineering, protein expression, and purification. Acquisitions of Xceleron and SNBL CPC have expanded the service portfolio.
Pharmaron's top competitors include Pfizer, Lonza and Boehringer Ingelheim.
Pharmaron has made 6 acquisitions, including Absorption, Aesica, and Allergan.
Pharmaron has 6 investors. Key investors include HHS, CITIC Capital, Legend Capital, DCM, and Aisling Capital.